Login
Companies $CLDX
$29.00 +$0.41 (1.43%) After hours
Celldex Therapeutics, Inc. logo

Celldex Therapeutics, Inc.

celldex.com

What Do They Do?

Develops antibody-based drug candidates for patients with severe inflammatory, allergic, autoimmune and other diseases, focusing on mast cell-driven conditions.

Who Are Their Customers?

Celldex performs manufacturing, research and development services for Rockefeller University under agreements, and earns revenue under drug-development agreements with collaborative partners.

Do Revenues Turn Into Profits?

No. It lost $258.8M in FY2025.

Operating income, FY2025
−18600% of revenue
▼ −47% (Loss) vs FY2024 (−$195.1M, −2779%)
Net income, FY2025
−16748% of revenue
▼ −64% (Loss) vs FY2024 (−$157.9M, −2249%)
Free cash flow, FY2025
−13829% of revenue
▼ −34% (Loss) vs FY2024 (−$159.7M, −2275%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▼ −13% (Loss)
vs −$67M in Q3 FY2025
  • Jul 15, 2026 CFO Sam Martin plans to retire He expects to remain through March 31, 2027, or until a successor starts; the company has begun a search.

Therapeutic focus The latest report centers the business description on mast cell biology and diseases mediated by mast cells; the older report also highlighted antibodies for many forms of cancer.

Program indications Atopic dermatitis is in the latest report's clinical portfolio, while the older report described a planned study in eosinophilic esophagitis.

Revenue over time
Product development and licensing agreements Contracts and grants
$10M$5M$0

Who Do They Compete With?

Competes with Abbvie, Akeso Bio, Amgen, Kiowa Kirin, Celltrion, Eli Lilly, Galderma, Chugai, Genentech, Novartis, Incyte, Kashiv Biosciences, Leo Pharma, Medimetriks, Pfizer, Regeneron, Sanofi, Teva, and Vanda Pharmaceuticals

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support